These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21809065)

  • 41. [Immunosuppression - too strong or too weak?].
    Schneidewind A; Fleck M; Salzberger B; Schölmerich J; Ehrenstein B
    Internist (Berl); 2009 Jun; 50(6):656-8. PubMed ID: 19424671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Everolimus and azoospermia, a causal relationship? About one case in a renal transplant patient].
    Wetzstein M; Weestel PF; Choukroun G
    Nephrol Ther; 2014 Feb; 10(1):44-5. PubMed ID: 24374233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Everolimus in cardiac-transplant recipients.
    Banas B; Böger C; Krämer B
    N Engl J Med; 2003 Dec; 349(23):2271-2; author reply 2271-2. PubMed ID: 14657441
    [No Abstract]   [Full Text] [Related]  

  • 44. Everolimus: an update on the mechanism of action, pharmacokinetics and recent clinical trials.
    Sánchez-Fructuoso AI
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):807-19. PubMed ID: 18611120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pulmonary embolism and reactivation of tuberculosis during everolimus therapy in a kidney transplant recipient.
    Fijałkowska-Morawska JB; Jagodzińska M; Nowicki M
    Ann Transplant; 2011; 16(4):107-10. PubMed ID: 22210429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Switch to everolimus for sirolimus-induced pneumonitis in a liver transplant recipient--not all proliferation signal inhibitors are the same: a case report.
    De Simone P; Petruccelli S; Precisi A; Carrai P; Doria R; Menichetti F; Filipponi F
    Transplant Proc; 2007 Dec; 39(10):3500-1. PubMed ID: 18089420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uneventful thoracic healing with everolimus after aortic valve replacement.
    Pascual J; Galeano C; Celemín D; Alarcón MC; Marcén R; Fernández AM; Burgos FJ; Ortuño J
    Ann Thorac Surg; 2007 Jul; 84(1):271-2. PubMed ID: 17588431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug reaction with eosinophilia and systemic symptoms syndrome caused by an everolimus-eluting stent.
    Bianchi L; Caraffini S; Lisi P
    Int J Dermatol; 2014 Apr; 53(4):e286-8. PubMed ID: 23967898
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical features and outcomes of patients with fever of unknown origin: a retrospective study.
    Tan Y; Liu X; Shi X
    BMC Infect Dis; 2019 Feb; 19(1):198. PubMed ID: 30813923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SDZ RAD. Rapamycin SDZ.
    Drugs R D; 1999 Jan; 1(1):97-9. PubMed ID: 10566000
    [No Abstract]   [Full Text] [Related]  

  • 51. [Persistent fever for more than 10 days in a urological patient].
    Biermann J
    Urologe A; 2016 Sep; 55(9):1218-20. PubMed ID: 27525428
    [No Abstract]   [Full Text] [Related]  

  • 52. [Fever of unknown origin in malignancies].
    Rieger CT; Peterson L; Ostermann H
    Internist (Berl); 2009 Jun; 50(6):685-90. PubMed ID: 19404586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diffuse alveolar hemorrhage induced by everolimus.
    Vandewiele B; Vandecasteele SJ; Vanwalleghem L; De Vriese AS
    Chest; 2010 Feb; 137(2):456-9. PubMed ID: 20133293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term pharmacokinetics of the metabolites of everolimus and cyclosporine in renal transplant recipients.
    Kirchner G; Mueller L; Winkler M; Loss M; Roechte F; Deters M; Christians U; Kaever V; Klempnauer J; Sewing K; Manns M
    Transplant Proc; 2002 Sep; 34(6):2233-4. PubMed ID: 12270379
    [No Abstract]   [Full Text] [Related]  

  • 55. Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.
    Lecefel C; Eloy P; Chauvin B; Wyplosz B; Amilien V; Massias L; Taburet AM; Francois H; Furlan V
    J Clin Pharm Ther; 2015 Feb; 40(1):119-20. PubMed ID: 25417855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fever of unknown origin: a challenging case.
    Vella S; Coleiro B; Mallia Azzopardi C
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29866675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sirolimus-induced drug fever and ciclosporin-induced leukencephalopathia with seizures in one liver transplant recipient.
    Schacherer D; Zeitoun M; Buttner R; Gelbmann C; Obed A; Schlitt HJ; Scholmerich J; Kirchner GI
    World J Gastroenterol; 2007 Dec; 13(45):6090-3. PubMed ID: 18023106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Everolimus: a review of its use in renal and cardiac transplantation.
    Dunn C; Croom KF
    Drugs; 2006; 66(4):547-70. PubMed ID: 16597167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral everolimus inhibits in-stent neointimal growth.
    Farb A; John M; Acampado E; Kolodgie FD; Prescott MF; Virmani R
    Circulation; 2002 Oct; 106(18):2379-84. PubMed ID: 12403670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [77-year-old female with temporal arteriitis, fever, exhaustion and cough].
    Fröhlich G; Märker-Hermann E; Ferrari M
    Dtsch Med Wochenschr; 2015 Mar; 140(6):393, 447. PubMed ID: 25774726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.